Nucleai

News

Sanofi backs precision oncology firm Nucleai in $33m fundrai...

Israeli startup Nucleai has raised $33 million in a second-round financing that will be used to further its work on using artificial inte

News

AI startup Nucleai has immuno-oncology treatment failures in...

Israeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond to immunotherapies, with the help of Swiss drugmaker De

News

NHS "isn't delivering equitable care for rare diseases"

A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks